Brown Brothers Harriman & CO Abbott Laboratories Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 2,347,313 shares of ABT stock, worth $264 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares

2,347,313

Previous 2,384,368 1.55%

Holding current value

$264 Million

Previous $248 Million 8.02%

% of portfolio

1.9%

Previous 1.95%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $3.71 Million - $4.38 Million	-37,055 Reduced 1.55%	2,347,313 $268 Million
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $4.79 Million - $5.34 Million	-47,504 Reduced 1.95%	2,384,368 $248 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $199,545 - $220,389	-1,822 Reduced 0.07%	2,431,872 $276 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $5.58 Million - $6.83 Million	-61,828 Reduced 2.48%	2,433,694 $268 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $6.6 Million - $7.91 Million	-69,036 Reduced 2.69%	2,495,522 $242 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $45.4 Million - $50.6 Million	450,343 Added 21.3%	2,564,558 $280 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $14.7 Million - $17.3 Million	152,166 Added 7.76%	2,114,215 $214 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $27.3 Million - $32 Million	-287,352 Reduced 12.77%	1,962,049 $215 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $598,073 - $692,457	6,181 Added 0.28%	2,249,401 $218 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $5.43 Million - $6.56 Million	-53,168 Reduced 2.32%	2,243,220 $244 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $7.05 Million - $8.6 Million	61,842 Added 2.77%	2,296,388 $272 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $1.75 Million - $2.14 Million	-15,152 Reduced 0.67%	2,234,546 $314 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $6.84 Million - $7.57 Million	-58,638 Reduced 2.54%	2,249,698 $266 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $1.01 Million - $1.19 Million	9,523 Added 0.41%	2,308,336 $268 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $233 Million - $274 Million	2,140,431 Added 1351.44%	2,298,813 $275 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $286,650 - $312,366	-2,730 Reduced 1.69%	158,382 $17.3 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $301,403 - $366,032	3,289 Added 2.08%	161,112 $17.5 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $126,799 - $162,288	1,656 Added 1.06%	157,823 $14.4 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $635,487 - $929,255	-10,116 Reduced 6.08%	156,167 $12.3 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $47,812 - $53,226	609 Added 0.37%	166,283 $14.4 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $71,446 - $77,470	-873 Reduced 0.52%	165,674 $13.9 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $367,315 - $428,400	-5,040 Reduced 2.94%	166,547 $14 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $1.13 Million - $1.37 Million	17,120 Added 11.08%	171,587 $13.7 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $2.32 Million - $2.63 Million	35,456 Added 29.79%	154,467 $11.2 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $63,485 - $76,587	1,044 Added 0.88%	119,011 $8.73 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $229,358 - $253,143	-3,984 Reduced 3.27%	117,967 $7.2 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $258,054 - $291,761	-4,586 Reduced 3.62%	121,951 $7.31 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $672,717 - $720,214	-12,532 Reduced 9.01%	126,537 $7.22 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $695,812 - $776,599	-14,478 Reduced 9.43%	139,069 $7.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	153,547	153,547 $7.46 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Abbott Laboratories Transaction History